NKGen Biotech ( NASDAQ: NKGN ) received a standard notice from Nasdaq that the company is not in compliance with Nasdaq Listing Rule because it had not timely filed its quarterly report on Form 10-Q. The Notice indicated that the company has 60 calendar days, or until October 21, 2024, to submit a plan to regain compliance. Source: Press Release More on NKGen Biotech Financial information for NKGen Biotech.